What is the announced value of the Baldwin take-private?

Baldwin disclosed an enterprise value of approximately $7.7 billion, comprising a $4.6 billion equity purchase price and $3.1 billion of net debt.

What will Baldwin shareholders receive?

Holders of Baldwin Class A common stock will receive $32.50 per share in cash, subject to the merger agreement. The filing separately addresses Class B shares and associated OpCo units, so it is inaccurate to describe every security as receiving identical cash consideration.

Who is acquiring Baldwin?

An acquisition vehicle formed by Sequence Holdings and DFO Management. DFO is Michael Dell’s family investment office. Eligible Baldwin colleagues will be able to roll a portion of their equity and retain a significant minority stake.

Is this a completed transaction?

No. A definitive agreement was announced on 14 September 2026. Closing is targeted for the first quarter of 2027 and remains subject to shareholder approval, regulatory approvals and customary conditions.

What premium does the offer represent?

The company states approximately 88% to Baldwin’s unaffected closing price on 17 June 2026. Structured market data shows a $17.33 close, which produces 87.5% by direct calculation.

What multiple does the deal imply?

Baldwin published approximately 20.0 times enterprise value to last-twelve-month Adjusted EBITDA of $396 million. Adjusted EBITDA is a company-defined non-GAAP measure.

How is the transaction financed?

The company says fully committed debt and DFO equity financing are in place and that the merger is not subject to a financing condition. The public announcement does not disclose the debt-equity split, pricing, maturities or post-close leverage.

How much debt is in the transaction value?

$3.1 billion of net debt, equal to approximately 40.3% of the stated enterprise value and 7.83 times the disclosed LTM Adjusted EBITDA. This bridge is not necessarily the funded closing leverage.

What is the strategic rationale?

Private ownership is intended to support longer-duration investment in AI-enabled workflow redesign, talent recruitment and colleague ownership. Baldwin says its strategy, leadership and culture will remain in place.

What does Sequence Holdings contribute?

Sequence describes itself as a permanent holding company with an engineering-led operating model and a proprietary platform called Atlas. It plans to work beside Baldwin’s operators to redesign workflows rather than simply deploy point tools.

DFO brings patient family-office capital associated with Michael Dell. The stated attraction is a long ownership horizon and founder alignment without a conventional fund expiry date.

What are the break fees?

The merger agreement provides a $170.334 million company termination fee in specified circumstances and a $276.218 million parent termination fee for specified parent breach or failure-to-close scenarios.

How strong was Baldwin’s recent operating performance?

Q2 2026 revenue was $492.9 million, up 30%, and Adjusted EBITDA was $116.7 million, up 37%. Organic revenue growth was 2%, which shows that acquired contribution drove a substantial portion of headline growth.

Why does the CAC transaction matter?

Baldwin completed the CAC combination in Q1 2026. The take-private therefore arrives during a large integration program, increasing management-execution risk while also creating a larger platform for the proposed AI operating model.

What happens to employee ownership?

Eligible colleagues can roll a portion of their equity and retain a significant minority stake. The public form of rollover agreement leaves holder-specific schedules blank, so the exact percentage and participant allocations are not disclosed.

What happens to the Tax Receivable Agreement?

The filed amendment caps final TRA payments at $298,450,598 at closing and then terminates the agreement. Public disclosure does not isolate whether that amount is inside the stated equity value or elsewhere in transaction funding.

What is the main underwriting risk?

The combination of a 20.0 times entry multiple, a material debt load, simultaneous CAC integration and an enterprise-wide AI transformation. The deal needs growth, margin expansion, deleveraging or strategic value to justify the price.

Who advised on the deal?

The buyer group used J.P. Morgan and Goldman Sachs as financial advisers and Latham & Watkins and Simpson Thacher as legal counsel. The independent special committee used Centerview and Wachtell Lipton. Baldwin also used Piper Sandler and Freshfields.

No relisting is committed. Trevor Baldwin wrote that it is possible, perhaps likely, that Baldwin could be public again one day, but the buyers describe patient capital and no exit timetable is disclosed.

Baldwin Group $7.7B Take-Private: Deal Terms & Valuation

Baldwin Group take-private — key transaction facts
Item	Detail
Target	The Baldwin Group, Inc. (Nasdaq: BWIN)
Acquirers	Sequence Holdings; DFO Management / Dell Family Office
Transaction	Take-private / majority acquisition
Announced	14 September 2026
Enterprise value	Approx. $7.7bn Disclosed
Equity purchase price	Approx. $4.6bn Disclosed
Net debt assumed or refinanced	Approx. $3.1bn Disclosed
Cash consideration	$32.50 per Class A share
Unaffected premium	Approx. 88% to 17 June 2026 close
LTM Adjusted EBITDA	Approx. $396m (company-defined non-GAAP)
Implied EV / LTM Adjusted EBITDA	Approx. 20.0x Disclosed
Expected close	Q1 2027
Status	Announced Definitive agreement; pending approvals

01 · Transaction overview

Baldwin Group Take-Private: $7.7 Billion Enterprise Value and Deal Structure

Definitive agreement signed 14 September 2026. Shareholder vote and regulatory approvals remain.

Sequence Holdings and DFO Management signed a definitive agreement on 14 September 2026 to acquire a majority interest in The Baldwin Group, Inc. (Nasdaq: BWIN) and take the company private at approximately $7.7 billion of enterprise value.

DFO Management and Sequence Holdings have agreed to acquire a majority interest in The Baldwin Group and take the Nasdaq-listed insurance distributor private. The 14 September Baldwin announcement confirms a $7.7bn enterprise value, a $4.6bn equity purchase price, $3.1bn of net debt and $32.50 in cash for each Class A share.²

The assignment headline attributes the $7.7bn figure to Financial Times reporting. The subsequent company announcement and SEC filing move that number from reported to confirmed public record. Reuters independently reported the same headline economics and identified DFO as Michael Dell’s family investment office.³

Eligible Baldwin colleagues can roll a portion of their equity and retain a significant minority stake. That makes the transaction neither a simple cash-out nor a conventional sponsor buyout with management sitting only in an incentive pool. It is a majority recapitalization around DFO capital, Sequence’s operating model and continuing employee ownership.

I have never been more convinced of a path than I am of this one.
Trevor Baldwin, chief executive, The Baldwin Group⁹

The target closing window is Q1 2027. Until the shareholder vote and regulatory conditions are satisfied, the transaction remains planned, not completed.

02 · Enterprise value

Baldwin Acquisition Value: Enterprise Value, Equity Value and Net Debt

Baldwin disclosed an approximately $7.7 billion enterprise value, comprising an approximately $4.6 billion equity purchase price and approximately $3.1 billion of net debt assumed or refinanced.

Transaction termsPublic record Acquiry calculation Not disclosed

Baldwin take-private transaction terms
Metric	Value
Acquirer group	Sequence Holdings and DFO Management, through Square Acquisition Parent, Inc.
Target	The Baldwin Insurance Group, Inc., Nasdaq: BWIN
Announced	14 September 2026
Enterprise value	$7.7bn Public record
Equity purchase price	$4.6bn
Net debt	$3.1bn; 40.3% of enterprise value Acquiry calculation
Class A consideration	$32.50 per share in cash
Unaffected premium	Approximately 88% to 17 June 2026 close
LTM Adjusted EBITDA	$396m; company-defined non-GAAP
EV / LTM Adjusted EBITDA	20.0×, published by Baldwin
Employee rollover	Eligible colleagues may roll a portion and retain a significant minority stake; exact percentage not disclosed
Financing	Fully committed debt and DFO equity; no financing condition
Company termination fee	$170.334m; 3.70% of equity value Acquiry calculation
Parent termination fee	$276.218m; 6.00% of equity value Acquiry calculation
Initial / extended outside date	14 June 2027 / 14 September 2027 if specified regulatory conditions remain
Approvals	Baldwin shareholder approval, regulatory approvals and customary conditions
Target close	Q1 2027
Status	Definitive agreement announced; pending

$7.7 Billion Enterprise Value

Baldwin published the $7.7 billion enterprise value in the 14 September announcement. It is a disclosed figure, not an Acquiry estimate.

$4.6 Billion Equity Purchase Price

The equity purchase price of approximately $4.6 billion is the cash-equity bridge before rollover detail. Exact sources and uses cannot be completed without the undisclosed rollover quantum.

$3.1 Billion Net Debt Assumed or Refinanced

Net debt of approximately $3.1 billion is 40.3% of enterprise value by Acquiry calculation. That ratio is the transaction bridge, not funded closing leverage.

Enterprise value split between equity and net debt

The published $7.7bn enterprise value bridges to a $4.6bn equity purchase price and $3.1bn of net debt.

Public record

Baldwin published all three figures. Net debt represents 40.3% of enterprise value. The bridge does not disclose the post-close financing mix or closing leverage.

View underlying data

Baldwin Group enterprise value components
Component	Value	% of enterprise value	Status
Equity purchase price	$4.6bn	59.7%	Disclosed
Net debt assumed or refinanced	$3.1bn	40.3%	Disclosed
Enterprise value	$7.7bn	100%	Disclosed

Source: The Baldwin Group transaction announcement; Acquiry calculations for percentages.

From equity purchase price to enterprise value

USD millions. This is the company-published transaction bridge, not a sources-and-uses statement.

Public record

$4.6bn of equity value plus $3.1bn of net debt equals the stated $7.7bn enterprise value. At $396m of LTM Adjusted EBITDA, the net-debt bridge equals 7.83x. That is not a forecast of funded closing leverage.

View underlying data

Baldwin Group enterprise value bridge
Step	Value (USD millions)	Type
Equity purchase price	4,600	Disclosed
Net debt	3,100	Disclosed
Enterprise value	7,700	Disclosed

Source: The Baldwin Group transaction announcement.

03 · Transaction structure

Baldwin Take-Private Structure and Employee Ownership

The buyers are using Square Acquisition Parent, Inc. to acquire a majority interest. Eligible Baldwin colleagues are expected to retain a significant minority equity stake; the exact rollover percentage is not disclosed.

BuyersSequence Holdings and DFO Management
Acquisition vehicleSquare Acquisition Parent, Inc., owned by Sequence AI Holdings, Inc.
TargetThe Baldwin Group, Inc. (Nasdaq: BWIN)
Rollover / minorityEligible colleagues — significant minority; percentage undisclosed

The buyer group is using Square Acquisition Parent, Inc., owned by Sequence AI Holdings, Inc., with two merger subsidiaries to collapse Baldwin’s public-company and OpCo structure. The legal architecture matters because Baldwin is an Up-C: the listed company owns a controlling interest in an operating partnership while pre-IPO members hold OpCo units and paired Class B shares.¹⁸

Under the filed mechanics, Class A shares receive $32.50 in cash. Class B shares are cancelled for no consideration because their economics sit with associated OpCo units; those units are separately cashed out, retained or rolled under the merger and support agreements. Any summary that says every Baldwin share receives $32.50 misses the Up-C mechanics.

UndisclosedThe rollover is strategically important and numerically opaque

The announcement says eligible colleagues will retain a significant minority stake. The public form of support and rollover agreement leaves holder-specific schedules blank.¹⁹ The exact ownership percentage, participating holders and individual elections are not public.

That limits any attempt to construct final sources and uses. Acquiry has not estimated the rollover quantum.

The Tax Receivable Agreement adds one more closing item. The filed amendment caps final TRA payments at $298,450,598 and terminates the agreement after payment.²⁰ The public documents reviewed do not isolate whether this sits within the $4.6bn equity price or elsewhere in funding requirements.

04 · Offer price and premium

BWIN Offer Price and Take-Private Premium

Class A shareholders will receive $32.50 per share in cash, an approximately 88% premium to the unaffected 17 June 2026 closing price of $17.33.

$32.50 Cash Consideration Per Share

Class A shares receive $32.50 in cash under the merger agreement. Class B shares are cancelled for no consideration because their economics sit with associated OpCo units.

Premium to the June 17, 2026 Unaffected Share Price

Baldwin anchors the premium to 17 June 2026, immediately before market speculation affected the stock. BWIN closed at $17.33 that day. The $32.50 offer is 87.5% higher by direct calculation, consistent with the company’s approximately 88% statement.

By 11 September, the last trading day before announcement, BWIN had already reached $29.65. The offer was 9.6% above that level. The stock closed at $32.00 on announcement day and $32.49 on 15 September, one cent below the offer.

BWIN price path into and through announcement

Selected closing prices from structured market data, compared with the $32.50 cash offer.

Public record

The offer is 87.5% above the $17.33 unaffected close on 17 June, consistent with the company’s “approximately 88%” disclosure. It is 9.6% above the 11 September close. BWIN closed at $32.49 on 15 September, one cent below the offer. The near-zero spread is a market observation, not a probability estimate.

View underlying data

BWIN selected closing prices versus the $32.50 offer
Observation	Date	Price (USD)
Unaffected close	17 Jun 2026	17.33
Pre-announcement close	11 Sep 2026	29.65
Announcement close	14 Sep 2026	32.00
Offer price	14 Sep 2026	32.50
First full day close	15 Sep 2026	32.49

Source: Yahoo Finance BWIN historical data via Manus Data API, 16 September 2026.

Interpretation: the unaffected premium captures value transferred relative to the pre-process price. The pre-announcement premium captures incremental value delivered at signing after the market had already capitalized the possibility of a transaction. Both are correct, and they answer different questions.

05 · The asset

Baldwin Group: Insurance Distribution Franchise

The Baldwin Group is a Tampa-based US insurance distributor serving more than three million clients across commercial, personal, employee benefits, specialty, reinsurance and risk-capital lines.

Baldwin distributes commercial and personal insurance, employee benefits, specialty products, reinsurance and risk-capital solutions. It reports serving more than three million clients. The attraction is a combination of recurring renewal economics, trusted producer relationships, carrier access, proprietary client and risk data, and regulatory standing that is slow to reproduce.

The 2025 annual report describes the listed parent as a holding company whose material asset is a controlling interest in Baldwin Holdings. At 20 February 2026, 96.7m Class A shares and 46.1m Class B shares were outstanding. The structure gave pre-IPO LLC members approval rights over specified major actions while ownership thresholds remained satisfied.¹⁸

The asset is not capital-light in the simple sense once acquisition debt is included. The operating model generates commissions, fees and cash, but Baldwin has compounded through M&A and entered 2026 with a large CAC transaction still integrating. This take-private therefore buys both a distribution franchise and an active transformation program.

06 · Financial performance

Baldwin Group Financial Performance

FY2025 revenue was $1.5 billion and Adjusted EBITDA was $341.5 million. Q2 2026 revenue was $492.9 million with Adjusted EBITDA of $116.7 million; cash conversion remains the harder underwriting line.

FY2025 revenue was $1.5bn and Adjusted EBITDA was $341.5m, up 8% and 9%, respectively. Adjusted free cash flow was $87.2m, or 25.5% of Adjusted EBITDA by Acquiry calculation.⁷

For the first half of 2026, revenue exceeded $1.0bn and Adjusted EBITDA reached $254.0m. Q2 revenue was $492.9m, Adjusted EBITDA was $116.7m and margin increased 110 basis points to 23.7%. Adjusted free cash flow in the quarter was $46.4m.⁶

Revenue, Adjusted EBITDA, Margins and Cash Flow

Operating scale before the take-private

Reported revenue, Adjusted EBITDA and adjusted free cash flow. USD millions; periods differ and are labelled.

Public record

FY2025 revenue was $1.5bn and Adjusted EBITDA was $341.5m. H1 2026 revenue exceeded $1.0bn and Adjusted EBITDA reached $254.0m after CAC joined the group. Adjusted EBITDA and adjusted free cash flow are Baldwin-defined non-GAAP measures.

View underlying data

Baldwin operating scale before the take-private
Metric	Period	Value (USD millions)	Basis
Revenue	FY2025	1,500	Reported
Revenue	H1 2026	1,024	Reported
Adjusted EBITDA	FY2025	341.5	Non-GAAP
Adjusted EBITDA	H1 2026	254.0	Non-GAAP
Adjusted FCF	FY2025	87.2	Non-GAAP
Adjusted FCF	H1 2026	46.2	Non-GAAP

Source: Baldwin FY2025 and Q2 2026 results. Adjusted EBITDA and adjusted FCF are company-defined non-GAAP measures.

Baldwin Adjusted EBITDA and Non-GAAP Financial MeasuresThe deal multiple uses Baldwin’s definition

Baldwin publishes the 20.0x price against LTM Adjusted EBITDA of $396m. That denominator excludes specified items under the company’s reconciliation. It should not be compared without adjustment to GAAP operating income, EBITDA, EBITDAC or a buyer’s synergy-adjusted measure.

07 · Reported vs organic growth

Baldwin Group Revenue Growth: Reported vs. Organic Growth

Q2 2026 headline revenue grew 30% while Baldwin’s company-defined organic revenue growth was 2%. Acquired contribution, including CAC Group, explains most of the gap.

Q2 2026 headline revenue grew 30%. Baldwin’s company-defined organic revenue growth was 2%. CAC Group revenue grew 23% on the comparison Baldwin provides. The gap is not an accounting error: it is evidence that acquired contribution, not organic production alone, is driving the step-up.

Headline growth against organic growth and cash conversion

Q2 2026 unless stated. Bars are normalized for visual comparison and labels carry the reported values.

Public recordAcquiry calculation

Q2 headline revenue growth

30% year on year

Revenue rose to $492.9m, including the contribution of CAC Group following the Q1 2026 combination.

Q2 organic revenue growth

2% year on year

Baldwin’s company-defined organic growth rate. The gap to headline growth shows the importance of acquired contribution.

Q2 adjusted EBITDA growth

37% year on year

Adjusted EBITDA reached $116.7m and margin expanded 110 basis points to 23.7%.

FY2025 adjusted FCF conversion

25.5% of Adjusted EBITDA

$87.2m of adjusted free cash flow divided by $341.5m of Adjusted EBITDA.

The 30% headline revenue increase includes acquisition contribution while organic revenue growth was 2%. The gap is the central quality-of-growth issue for underwriting. The 25.5% FY2025 adjusted free-cash-flow conversion is an Acquiry calculation from company-defined non-GAAP measures.

View underlying data

Headline growth against organic growth and cash conversion
Metric	Display	Period	Status
Q2 headline revenue growth	30%	Q2 2026	Disclosed
Q2 organic revenue growth	2%	Q2 2026	Disclosed
Q2 adjusted EBITDA growth	37%	Q2 2026	Disclosed
FY2025 adjusted FCF conversion	25.5%	FY2025	Acquiry calculation

Source: Baldwin Q2 2026 results; FCF conversion is an Acquiry calculation.

That distinction is central to the take-private. A 20.0x LTM Adjusted EBITDA price can be supported by durable organic growth, margin expansion, accretive consolidation and deleveraging. If growth remains acquisition-dependent, the capital requirement and integration burden stay high. If organic production accelerates while CAC synergies land, the entry multiple compresses faster.

The missing decision-grade disclosures are customer retention, producer retention, top-client concentration, net new business, renewal pricing contribution and conversion from adjusted EBITDA to unlevered free cash flow. None should be guessed.

08 · Buyer structure

DFO Management and Sequence Holdings: Buyer Structure

DFO Management, Michael Dell’s family investment office, is providing patient capital. Sequence Holdings is the engineering-led operating partner. The transaction is framed as an operating-model transformation, not only financial engineering.

Strategic rationale, assessedAcquiry inference

Rationale	Evidence	Reality check	Support
Private ownership for long-duration investment	DFO and Sequence describe patient capital; Baldwin says strategy and leadership remain.	Private ownership removes public reporting pressure, not debt-service or execution constraints.	Strong
AI workflow redesign	Sequence built Atlas and publishes a defined “refounding” operating model. Baldwin says its AI work is already under way.	BankSouth is an early proof point, not proof at Baldwin’s scale and complexity.	Strong thesis
Talent advantage	Baldwin identifies accelerating producer mobility and plans wider colleague ownership.	Retention economics and rollover participation are not disclosed.	Moderate
CAC integration and margin expansion	CAC creates a broader, scaled platform with targeted synergies.	Integration is recent and now overlaps with ownership and technology change.	Moderate
Future strategic optionality	Trevor Baldwin says a future return to public markets is possible.	No exit route, timing or valuation is committed.	Directional

The clearest strategic fit is between Baldwin’s proprietary workflows and data, Sequence’s engineering team and DFO’s ownership horizon. The weak version of the thesis is “add AI.” The investable version is redesigning quote, placement, renewal, claims, data and administrative workflows while protecting producer judgment and client relationships.

10 · BankSouth reference case

BankSouth as a Sequence Holdings Reference Case

BankSouth is discussed here as a reference case for Sequence Holdings’ operating model, not as an asset involved in the Baldwin transaction.

Sequence’s first disclosed partnership was a minority financial and hands-on operating investment in BankSouth, a $1.6bn-asset community bank. Sequence later reported that BankSouth’s loan origination process fell from nine stages to three, time from application to closing fell approximately 52%, and loan volume doubled with the same team.¹¹

Those are company-reported outcomes. They are relevant because they describe the intended mechanism: reduce middle- and back-office friction so relationship professionals can support more volume. They are not directly transferable because Baldwin is larger, more acquisitive, multi-line, carrier-dependent and distributed across more workflows and jurisdictions.

Acquiry inferenceWhat would validate the thesis at Baldwin

Cycle time from client data collection to market submission. Percentage of submissions requiring rework. Producer time spent on administration. Renewal throughput per service colleague. Quote-to-bind conversion. Carrier appetite-match accuracy. Client retention. Error and exception rates. Margin lift net of technology and change costs.

Publishing any five of these consistently would move the AI thesis from narrative to operating evidence.

11 · AI thesis

Baldwin AI Thesis: What Has Been Disclosed and What Remains Speculative

Management frames AI as capacity creation — less rekeying and reconciliation, more advisory time. Sequence has not disclosed a Baldwin-specific productivity target, budget or first workflow.

Disclosed intention

Trevor Baldwin’s stakeholder letter frames AI as a way to remove gathering, rekeying, reconciling and chasing so advisers and underwriters can spend more time on judgment and relationships. It also identifies predictive pricing, claims analytics, appetite matching, proprietary product development and faster claims service as longer-term opportunities.⁹

That framing is commercially sound. In insurance distribution, blunt labor removal can destroy the client and carrier relationships that generate renewal revenue. Capacity creation is more defensible: the same producer and service base can handle more clients, pursue more new business and spend more time on complex risk.

What remains speculative

The weak assumption is that technology alone produces the value. Baldwin must standardize data definitions, permissions and workflows across acquired businesses; govern model output; redesign incentives; and preserve accountability. Sequence brings engineers and an operating thesis. Baldwin must supply domain ownership and adoption.

12 · Comparable transactions

Insurance Brokerage M&A Context and Comparable Transactions

The disclosed 20.0x LTM Adjusted EBITDA multiple sits above Gallagher’s 14.3x gross AssuredPartners EBITDAC multiple. Denominators differ; the comparison shows direction, not equivalence.

Gallagher agreed to pay $13.45bn for AssuredPartners at 14.3x pro forma LTM EBITDAC. Gallagher presented 11.3x after a $1.0bn deferred tax asset and $160m of expected synergies.¹⁵ Baldwin bought CAC at 7.9x 2025E pro forma Adjusted EBITDA including targeted full run-rate synergies.⁸

Disclosed insurance-broker transaction multiples

EV / EBITDA-family measures. Denominators differ materially; this is a reference set, not a valuation answer.

Public record

Baldwin’s 20.0x is on LTM Adjusted EBITDA. Gallagher’s 14.3x for AssuredPartners is on pro forma LTM EBITDAC before tax assets and synergies; 11.3x is after both. CAC’s 7.9x includes targeted full run-rate synergies. The chart makes the entry premium visible, not directly comparable.

View underlying data

Disclosed insurance-broker transaction multiples
Target	Buyer	Year	Multiple	Denominator	Comparability notes
Baldwin	DFO + Sequence	2026	20.0x	LTM Adjusted EBITDA	Headline disclosed multiple; no synergy credit
AssuredPartners	Gallagher	2024	14.3x	Pro forma LTM EBITDAC, gross	Different denominator (EBITDAC)
AssuredPartners	Gallagher	2024	11.3x	Net of DTA and synergies	Gives credit for tax asset and synergies
CAC Group	Baldwin	2025	7.9x	2025E pro forma Adj. EBITDA incl. synergies	Forward, synergy-inclusive denominator

Source: Company announcements. Denominators are not equivalent.

The comparison has limits. EBITDAC differs from Adjusted EBITDA. AssuredPartners’ net multiple gives credit for tax assets and synergies; Baldwin’s headline multiple does not. CAC uses a forward, synergy-inclusive denominator. The defensible conclusion is only that Baldwin enters at a visibly higher published multiple.

Other scale markers support the strategic scarcity argument. Brown & Brown agreed to pay $9.825bn for Accession, which had $1.7bn of 2024 pro forma adjusted revenue.¹⁶ Marsh McLennan paid $7.75bn for McGriff, which had $1.3bn of LTM revenue and a $500m deferred tax asset.¹⁷ Neither primary release reviewed publishes a directly comparable EBITDA multiple.

13 · Market context

Insurance Distribution M&A Market Context

US insurance brokerage remains a consolidating, cash-generative category. Scarcity at Baldwin’s scale supports strategic demand; it does not eliminate entry-price discipline.

MarshBerry reports $83.3bn of 2025 revenue across the Top 100 US brokers, with the top ten producing $58.5bn, or 70%. It counted 854 announced US insurance brokerage transactions in 2025.¹²

PwC reports $29.6bn of announced US insurance deal value across 191 disclosed transactions from 1 December 2025 through 31 May 2026. Its 2026 outlook identifies public-broker valuation compression, technology investment and AI uncertainty as live factors in distribution M&A.¹³

Fitch’s sector view explains the leverage attraction and the risk. Insurance brokers combine recession resistance and robust free cash flow, but debt-funded acquisitions can weaken credit metrics. Fitch notes some sponsor-owned brokers operate at 8x to 10x EBITDA leverage or higher, sometimes with interest coverage below 1.5x.¹⁴ That is sector context, not a statement of Baldwin’s closing leverage.

Baldwin sits in the scarce middle: large enough to have national scale and specialty capabilities, still small enough for a private acquisition vehicle, and carrying internal transformation potential. That scarcity supports strategic demand. It does not eliminate entry-price discipline.

14 · Financing and capital structure

Transaction Financing and Capital Structure

Debt commitment letters and a DFO equity commitment are disclosed, and the merger is not subject to a financing condition. Debt quantum, pricing, maturities and post-close leverage are not disclosed.

The 8-K says Parent has debt commitment letters and an equity commitment from DFO. The transaction is not subject to a financing condition.⁴ That materially strengthens closing certainty relative to a deal conditioned on raising capital.

Baldwin take-private capital stack showing DFO equity, committed debt and employee rollover supporting the insurance platform — Three layers carry the transaction: DFO equity, committed debt and continuing colleague ownership. The public filing confirms commitment, not the final quantum or cost of each layer.

Capital-stack visibilityPublic record Not disclosed

Item	Status	Decision implication
Enterprise value	$7.7bn disclosed	Reliable headline scale
Equity purchase price	$4.6bn disclosed	Reliable cash-equity bridge before rollover detail
Net debt	$3.1bn disclosed	Reliable transaction bridge, not final funded leverage
Debt commitment	Confirmed	Reduces financing-condition risk
DFO equity commitment	Confirmed	Identifies primary equity backstop
Debt quantum, price and maturity	Not disclosed	Cannot model interest coverage or deleveraging
Rollover quantum	Not disclosed	Cannot complete sources and uses
Post-close leverage target	Not disclosed	Core returns and downside variable remains open

The $3.1bn net-debt bridge equals 7.83x the disclosed $396m LTM Adjusted EBITDA. That ratio is not closing leverage. Existing debt may be repaid, refinanced or supplemented, and rollover reduces cash equity required. The real model begins only when the final debt schedule is public.

15 · Closing conditions

Closing Conditions, Fees and Outside Dates

Closing remains subject to Baldwin shareholder approval, regulatory approvals and customary conditions. Target close is Q1 2027, with an initial outside date of 14 June 2027.

The merger agreement provides a $170.334m company termination fee for specified superior-proposal and recommendation-change circumstances, equal to 3.70% of the stated equity purchase price. The parent termination fee is $276.218m for specified parent breach or failure-to-close scenarios, equal to 6.00% of equity value.⁵

The 1.62x ratio between parent and company fees allocates more financial consequence to buyer failure. It is consistent with a transaction dependent on a private acquisition vehicle and committed financing, while preserving Baldwin’s fiduciary out for an unsolicited superior proposal before the shareholder vote.

The initial outside date is 14 June 2027. It automatically extends to 14 September 2027 if specified regulatory conditions remain outstanding while other conditions are satisfied or waived. This is a practical signal: the contract treats regulatory timing, not financing availability, as the likely source of long-stop delay.

16 · Ownership and alignment

Baldwin Ownership, Rollover and Alignment

DFO and Sequence acquire control. Eligible colleagues may roll equity and retain a significant minority stake. The public form agreement leaves holder-specific rollover schedules blank.

Baldwin presents broad colleague ownership as a defining element of its culture. The transaction preserves that principle for eligible employees through rollover and a significant minority interest. DFO and Sequence acquire control; management and colleagues retain economic participation.

The alignment benefit is clear. Producers and executives can participate in value creation after close rather than receiving cash only. The governance trade-off is equally clear. Public shareholders lose liquidity and future upside beyond $32.50, while continuing holders accept private valuation, transfer and exit constraints that are not described in the public form agreement.

A robust closing analysis needs the final rollover percentage, voting and board rights, dilution provisions, leaver terms, liquidity rights and future equity plan. None are in the public record reviewed.

17 · Integration risks

Baldwin Integration Risks After the CAC Combination

CAC closed in Q1 2026. The take-private therefore overlaps with an active integration program and a planned AI workflow redesign. Sequencing, not speed, is the operating constraint.

CAC was announced in December 2025 and closed in Q1 2026. The combination brought a $1.026bn upfront price, up to $250m of earnout, a $70m deferred payment and expectations of more than $2bn of 2026 revenue and more than $470m of Adjusted EBITDA.⁸

Baldwin and CAC insurance operating systems aligning during the DFO and Sequence take-private integration — CAC integration, ownership transition and AI workflow redesign will overlap. The systems can align, but the narrow seam is management capacity.

There are three simultaneous workstreams: finish CAC integration, close and finance the take-private, and accelerate enterprise-wide technology transformation. Each is manageable alone. Together they create sequencing risk, change fatigue, data migration complexity and potential distraction for producers and client teams.

The correct integration principle is not maximum speed everywhere. It is a controlled sequence: protect client and carrier continuity, stabilize CAC data and governance, select high-friction workflows, prove outcomes in bounded domains, then scale. Any plan that attempts a whole-enterprise redesign before the operating baseline is stable is weak.

18 · Strategic implications

Acquiry Analysis: Strategic Implications of the Baldwin Take-Private

The immediately visible benefits are a longer ownership horizon and broader colleague ownership. AI productivity, organic-growth recovery and margin expansion require operating evidence that has not been published.

Value-creation levers and Acquiry confidence

Confidence reflects evidence of deliverability, not the size of potential value.

Acquiry inference

AI-enabled workflow redesign

High confidence

12-36 months

Sequence’s Atlas model targets process redesign across advisory, placement, underwriting support and back office. The operating thesis is explicit; the value quantum is not disclosed.

Talent recruitment and retention

High confidence

0-24 months

Baldwin identifies talent mobility as a structural opportunity and plans broader ownership for colleagues. Exact rollover and incentive participation are not disclosed.

Margin expansion from integration

Moderate confidence

12-36 months

CAC adds scale, specialization and a broader platform. Synergy execution and simultaneous AI transformation create delivery risk.

Organic growth recovery

Low confidence

4-8 quarters

Q2 2026 organic growth was 2%, materially below headline growth. The deal case improves if Baldwin restores stronger organic production without sacrificing retention.

Lower public-market friction

High confidence

Immediate

Private ownership removes quarterly market pressure and provides a longer investment horizon. It does not remove debt-service, regulatory or execution constraints.

The highest-confidence benefits are a longer ownership horizon and greater ability to invest through reporting cycles. The largest potential benefit, enterprise-wide AI workflow redesign, is also the most execution-dependent.

View underlying data

Value-creation levers and Acquiry confidence
Lever	Confidence (1–5)	Horizon	Notes
AI-enabled workflow redesign	4	12-36 months	Thesis explicit; value quantum undisclosed
Talent recruitment and retention	4	0-24 months	Rollover participation undisclosed
Margin expansion from integration	3	12-36 months	Overlaps with AI change
Organic growth recovery	2	4-8 quarters	Q2 organic growth was 2%
Lower public-market friction	4	Immediate	Does not remove debt-service constraints

Source: Acquiry inference. Confidence reflects evidence of deliverability, not value size.

The immediate benefits are governance and time horizon. Private ownership can move capital and organizational attention without quarterly public-market signaling. Talent ownership can be widened and made more specific to performance.

AI productivity, organic growth recovery and margin expansion take longer and require operating evidence. Acquiry does not attach a dollar synergy estimate because the buyer has published none and the available process metrics do not support one.

19 · Transaction risks

Baldwin Transaction Risks and Key Unknowns

Financing detail and simultaneous CAC-plus-AI execution are the two severity-five risks. Scenarios below are Acquiry inference, not disclosed facts.

Take-private risk register

Eight items scored on severity and likelihood. Positions are Acquiry inference; hover for evidence and resolution path.

Acquiry inference

Severity 5Severity 4Severity 3 or below

Financing and execution overlap are the two severity-five risks. The $276.218m parent termination fee and absence of a financing condition reduce closing-risk asymmetry, but they do not establish the economics of the post-close capital stack.

View underlying data

Take-private risk register
#	Risk	Category	Severity	Likelihood	Resolves
1	Pro forma leverage and financing cost	Capital structure	5	4	Closing debt schedule
2	CAC integration and AI transformation overlap	Integration	5	3	2027 retention and margin metrics
3	Organic growth quality	Commercial	4	4	Four quarters of organic revenue
4	Insurance regulatory approvals	Execution	4	3	Clearance milestones
5	AI delivery and model risk	Technology	4	3	Documented productivity and controls
6	Key producer and colleague retention	Human capital	4	3	Rollover and 2027 retention
7	Valuation and multiple compression	Returns	3	4	EBITDA growth and deleveraging
8	Up-C and TRA closing complexity	Legal and tax	3	2	Final proxy and TRA payment

Source: Acquiry inference. Positions are not company-disclosed scores.

Baldwin transaction risks and downside scenariosAcquiry inference

Failure mode	Mechanism	Leading indicator	Mitigation
Organic growth stays low	Multiple compression and slower deleveraging	Organic growth below mid-single digits for four quarters	Producer recruitment, cross-sell and retention accountability
CAC integration slips	Duplicate cost, data friction and producer attrition	Delayed systems milestones, elevated exceptions	Ring-fenced integration office and sequenced AI rollout
AI program scales before controls	Error, regulatory, privacy and client-trust risk	Rising override and rework rates	Human decision rights, audit logs and bounded deployments
Debt cost stays high	Free cash flow diverted from investment and M&A	Weak interest coverage and limited debt paydown	Conservative leverage, fixed-rate protection and cash discipline
Producer retention weakens	Client leakage and organic-growth pressure	Elevated voluntary attrition and book transfers	Clear ownership economics and local leadership continuity

20 · Timeline

Baldwin Take-Private Timeline

The definitive agreement was announced on 14 September 2026. Closing is targeted for Q1 2027. The merger agreement sets an initial outside date of 14 June 2027.

Transaction and operating sequence

From public listing through CAC integration, take-private announcement and contractual outside dates.

Public recordAcquiry inference

The announced target is Q1 2027. The merger agreement sets an initial outside date of 14 June 2027 and an automatic extension to 14 September 2027 if specified regulatory conditions remain outstanding. The extension architecture identifies regulatory timing as the principal long-stop risk.

View underlying data

Transaction and operating sequence
Date	Event	State	Status
24 Oct 2019	Baldwin completes initial public offering	done	Disclosed
2 Dec 2025	CAC Group combination announced	done	Disclosed
Q1 2026	CAC Group combination closes	done	Disclosed
17 Jun 2026	Unaffected BWIN close of $17.33	done	Market data
14 Sep 2026	Definitive take-private agreement announced	current	Disclosed
Q4 2026	Proxy, shareholder vote and regulatory review	pending	Acquiry inference
Q1 2027	Target closing window	pending	Disclosed
14 Jun 2027	Initial outside date	future	Disclosed
14 Sep 2027	Regulatory extension date if conditions apply	future	Disclosed

Source: Baldwin announcements and merger agreement; Q4 2026 proxy timing is Acquiry inference.

21 · Consequences

Who Gains Leverage From the Baldwin Take-Private

Public Class A shareholders receive $32.50 in cash. Sequence secures a scaled distribution platform for Atlas. Competing consolidators face a privately controlled peer with patient capital.

Gaining leverage

Baldwin public shareholders

Receive $32.50 cash, approximately 88% above the unaffected close and effectively at the first full post-announcement trading price.

Baldwin management and eligible colleagues

Retain minority participation while gaining patient capital and an engineering operating partner.

Sequence Holdings

Secures a scaled, data-rich flagship for its refounding model after an early BankSouth proof point.

DFO Management

Acquires control exposure to a resilient distribution category with consolidation and technology optionality.

Insurance-broker sellers

Gain a new 20.0x disclosed reference point, subject to denominator and structure discipline.

Facing a harder conversation

Competing broker consolidators

Face a privately controlled competitor with patient capital, broad employee ownership and a dedicated engineering platform.

Baldwin creditors

Need to assess refinancing, leverage, integration and technology investment against free cash flow.

Public broker investors

Must separate takeover scarcity premiums from operating valuation and compare non-GAAP denominators carefully.

Baldwin integration leaders

Inherit CAC integration, ownership transition and AI transformation in overlapping windows.

Technology vendors

Compete with a buyer that intends to build an internal operating layer rather than purchase disconnected tools.

22 · Acquiry analysis

Acquiry Analysis: What the Baldwin Transaction Could Mean

Acquiry’s view: the structure is credible, the 20.0x LTM Adjusted EBITDA entry is full, and returns depend on execution quality rather than purchase-price arbitrage. This is interpretation, not a disclosed fact.

Acquiry verdict · 16 September 2026

A premium-control transaction whose returns depend on execution quality more than purchase-price arbitrage.

On structure, closing certainty is credible. The price is confirmed, financing is committed, the deal is not subject to a financing condition, the board acted through an independent special committee, and the parent reverse fee exceeds the company fee.

On valuation, 20.0x LTM Adjusted EBITDA is full. It is above the gross AssuredPartners precedent and far above Baldwin’s own synergy-inclusive CAC entry multiple. Denominators differ, but the premium direction is not ambiguous.

On strategic logic, the buyer group fits the stated problem. DFO supplies patient capital. Sequence supplies engineering and an operating doctrine. Baldwin supplies scale, workflows, proprietary data, distribution and management continuity. The transaction gives all three a reason to remain aligned.

On downside, the stress point is simultaneous change under leverage. CAC integration is recent. Organic growth was 2% in Q2. AI transformation requires process and control redesign, not software installation. The debt schedule is not public.

Net. This is not a cheap broker consolidation. It is a high-conviction take-private priced for Baldwin to become a better operating platform. The deal works if AI-led capacity, producer retention, CAC integration and organic growth compound faster than financing cost and entry-multiple compression.

Strategic logic

Strong

Entry valuation

Full

Closing structure

Credible

Execution complexity

High

DFO Management and Sequence Holdings enclosing Baldwin's national insurance distribution network in a $7.7 billion take-private — The transaction puts a scaled insurance network inside two long-duration capital and operating arcs. The protected platform is valuable; the return depends on what happens inside it.

23 · What to watch

Baldwin Take-Private: What To Watch Next

The next decision-grade disclosures are funded leverage, rollover percentage, organic-growth recovery, CAC synergy delivery and the first Atlas workflow.

Investor and operator watch listAcquiry inference

#	Question	Where it resolves	Timing
1	What is final funded leverage?	Closing debt documents, ratings or lender disclosures	At close
2	Does organic growth recover from 2%?	Quarterly results before close; private KPI reporting after	4-8 quarters
3	What percentage rolls?	Proxy, final support schedules or closing disclosure	Before or at close
4	Which regulatory approvals govern timing?	Proxy and clearance announcements	Q4 2026-Q1 2027
5	Are CAC synergies and retention on plan?	2026 results and integration reporting	Q4 2026-Q2 2027
6	Which workflow becomes the first Atlas deployment?	Company operating update	Post-close
7	Are AI outcomes measured against control quality?	Cycle time, rework, override and exception metrics	6-18 months
8	Do producers and specialist teams stay?	Voluntary attrition and book retention	12-24 months
9	How quickly does debt reduce?	Private credit reporting, refinancing or eventual relisting materials	12-36 months
10	Does Baldwin return to public markets?	Owner decision; no committed timetable	Long term

24 · Confirmed vs undisclosed

What Is Confirmed, Calculated and Still Undisclosed

Headline economics — enterprise value, equity purchase price, offer price, premium and the 20.0x LTM Adjusted EBITDA multiple — are company-disclosed. The final post-close financing mix, rollover percentage and AI investment budget are not publicly confirmed.

Information statusDisclosed Acquiry calculation Undisclosed

Baldwin take-private: confirmed, calculated and undisclosed items
Item	Status	Value / conclusion	Source
Enterprise value	Disclosed	~$7.7bn	Baldwin announcement
Equity purchase price	Disclosed	~$4.6bn	Baldwin announcement
Net debt	Disclosed	~$3.1bn	Baldwin announcement
Offer price	Disclosed	$32.50 per Class A share	Merger agreement
Unaffected premium	Disclosed	~88% to 17 June 2026	Transaction announcement
LTM Adjusted EBITDA	Disclosed (non-GAAP)	~$396m	Baldwin announcement
EV / LTM Adjusted EBITDA	Disclosed	~20.0x	Baldwin announcement
Net debt / LTM Adjusted EBITDA	Acquiry calculation	~7.83x; not closing leverage	Acquiry calculation
Company termination fee	Disclosed	$170.334m	Merger agreement
Parent termination fee	Disclosed	$276.218m	Merger agreement
Expected close	Disclosed	Q1 2027	Baldwin announcement
Final financing mix	Undisclosed	Not publicly confirmed	N/A
Rollover ownership %	Undisclosed	Not publicly confirmed	N/A
AI investment budget	Undisclosed	Not publicly confirmed	N/A
Post-close governance	Undisclosed	Not publicly confirmed	N/A

Known

$7.7bn enterprise value
$4.6bn equity purchase price
$32.50 cash offer
Expected Q1 2027 close

Not fully disclosed

Final post-close debt structure
Detailed technology investment budget
Precise employee rollover ownership
Full post-close governance arrangements

25 · Sources and methodology

Sources and Methodology

Primary company and SEC disclosures rank above reporting. Calculations use disclosed inputs and show the basis. Missing capital-stack, rollover and operating data are identified rather than estimated.

Twenty public sources underpin the transaction terms, operating baseline, sector context and Acquiry calculations. Every non-Acquiry row links to the original source. Full method: How Acquiry analyses transactions.

Research methodology Source policy Corrections policy Source ledger

01Business Wire transaction announcement, 14 September 2026Primary distribution record for price, premium, structure, rationale, financing, approvals, advisers and target closing window.Primary

02The Baldwin Group transaction announcementCompany-hosted primary source for the definitive agreement and headline terms.Primary

03Reuters, 14 September 2026Independent coverage of the $7.7bn transaction, buyer group and market reaction.Reported

04Baldwin Form 8-K, filed 14 September 2026Legal entities, board process, financing commitments, support and rollover arrangements, TRA amendment and merger mechanics.SEC

05Agreement and Plan of MergerClass-level consideration, conditions, fiduciary out, $170.334m company fee, $276.218m parent fee and contractual outside dates.SEC

06Baldwin Q2 2026 resultsQuarterly and half-year revenue, organic growth, Adjusted EBITDA, margin, cash flow, cash and debt.Primary

07Baldwin FY2025 resultsFY2025 revenue, Adjusted EBITDA, margin, free cash flow and strategic baseline.Primary

08Baldwin and CAC Group combination announcementPurchase consideration, expected revenue and EBITDA, 7.9x synergy-inclusive multiple, earnout and financing.Primary

09Trevor Baldwin, “The Moment for Builders”Management rationale for private ownership, AI redesign, talent investment, ownership and possible future public status.Primary

10Sequence Holdings, “Built to Refound”Sequence operating model, Atlas platform, engineering capability, service-economy focus and Baldwin rationale.Primary

11BankSouth partnership with Sequence HoldingsFirst disclosed Sequence investment and operating context; later Sequence article supplies claimed process outcomes.Primary

12MarshBerry, 2026 Top 100 insurance brokersUS broker revenue concentration, growth and 2025 brokerage transaction count.Industry

13PwC 2026 US insurance deals outlookDeal value and volume, distribution trends, valuation compression and technology themes.Industry

14Fitch, US insurance brokers and larger acquisitionsSector cash generation, debt-funded acquisition risk, leverage and interest-coverage context.Ratings

15Gallagher / AssuredPartners announcement$13.45bn consideration, $938m pro forma LTM EBITDAC, 14.3x gross and 11.3x net multiple.Primary

16Brown & Brown / Accession announcement$9.825bn purchase price, $1.7bn revenue and operating scale; no primary EBITDA multiple disclosed.Primary

17Marsh McLennan / McGriff announcement$7.75bn cash consideration, $1.3bn LTM revenue and $500m deferred tax asset.Primary

18Baldwin 2025 Form 10-KUp-C structure, share counts, OpCo ownership, TRA mechanics, business description and governance rights.SEC

19Voting, support and rollover agreement formRollover architecture; holder-specific schedules are blank in the public form.SEC

20Tax Receivable Agreement amendmentFinal-payment cap of $298,450,598 and termination after closing payment.SEC

21Yahoo Finance BWIN historical dataDaily closes used for unaffected, pre-announcement and post-announcement market-price calculations; retrieved via Manus Data API on 16 September 2026.Market data

22Acquiry Deal Intelligence calculationsPremium calculations, net debt share of EV, fee percentages, net debt / LTM Adjusted EBITDA, FCF conversion, risk scores and strategic assessment.Acquiry

Section	Sources
What happened and terms	01-05
Structure and ownership	04, 05, 18-20
Public-market path	01, 21, 22
Asset and financial baseline	06, 07, 18
Quality of growth	06, 22
Buyer rationale and AI thesis	09-11
Precedents	08, 15-17
Market context	12-14
Financing and protections	04, 05, 19, 20
Integration, levers and risk	06, 08-11, 22
Timeline and verdict	01-05, 22

The Baldwin Group $7.7 Billion Take-Private: Deal Terms, Valuation and Strategic Analysis

Baldwin Group Take-Private: $7.7 Billion Enterprise Value and Deal Structure

Baldwin Acquisition Value: Enterprise Value, Equity Value and Net Debt

$7.7 Billion Enterprise Value

$4.6 Billion Equity Purchase Price

$3.1 Billion Net Debt Assumed or Refinanced

Baldwin Take-Private Structure and Employee Ownership

BWIN Offer Price and Take-Private Premium

$32.50 Cash Consideration Per Share

Premium to the June 17, 2026 Unaffected Share Price

BWIN Share Price Before and After the Transaction Announcement

Baldwin Group: Insurance Distribution Franchise

Baldwin Group Financial Performance

Revenue, Adjusted EBITDA, Margins and Cash Flow

Baldwin Group Revenue Growth: Reported vs. Organic Growth

DFO Management and Sequence Holdings: Buyer Structure

Sequence Holdings and the AI Operating Model

Sequence’s Atlas Platform

BankSouth as a Sequence Holdings Reference Case

Baldwin AI Thesis: What Has Been Disclosed and What Remains Speculative

Disclosed intention

What remains speculative

Insurance Brokerage M&A Context and Comparable Transactions

Insurance Distribution M&A Market Context

Transaction Financing and Capital Structure

Closing Conditions, Fees and Outside Dates

Baldwin Ownership, Rollover and Alignment

Baldwin Integration Risks After the CAC Combination

Acquiry Analysis: Strategic Implications of the Baldwin Take-Private

Baldwin Transaction Risks and Key Unknowns

Baldwin Take-Private Timeline

Who Gains Leverage From the Baldwin Take-Private

Acquiry Analysis: What the Baldwin Transaction Could Mean

Baldwin Take-Private: What To Watch Next

What Is Confirmed, Calculated and Still Undisclosed

Sources and Methodology

References, citation and open questions

APA, 7th edition

Chicago, author-date

BibTeX

Editorial independence

Corrections and updates

Not investment advice

Positions

Method

Related Acquiry Deal Intelligence

Acquiring or selling a digital business between $1m and $500m?